Advertisement
RayBiotech
RayBiotech

The Scientist

» cancer, disease/medicine and ecology

Most Recent

image: Edible Marijuana Labels Wrong

Edible Marijuana Labels Wrong

By | June 24, 2015

The dosage information on 83 percent of 75 edible marijuana products legally sold in Seattle, San Francisco, and Los Angeles was incorrect.

2 Comments

image: Tracing Ebola’s Evolution

Tracing Ebola’s Evolution

By | June 18, 2015

Two independent teams examine the migration and evolution of the virus throughout the ongoing outbreak in West Africa.

0 Comments

image: Ebola Virus Virulence

Ebola Virus Virulence

By | June 9, 2015

The strain of Ebola that has circulated in West Africa for the last year takes longer to kill macaques than the virus that caused an outbreak in Central Africa in 1976.

0 Comments

image: More Lab-Made Nucleotides

More Lab-Made Nucleotides

By | June 8, 2015

Artificial bases that act like the real deal can be designed to bind specifically to tumor cells.

0 Comments

image: Drug for Low Sex Drive in Women?

Drug for Low Sex Drive in Women?

By | June 8, 2015

A federal advisory panel supports the US Food and Drug Administration’s approval of the first drug for female sexual dysfunction.

1 Comment

image: The Roots of Schizophrenia

The Roots of Schizophrenia

By | June 4, 2015

Researchers link disease-associated mutations to excitatory and inhibitory signaling in the brain.

0 Comments

image: NCI Gets Personal

NCI Gets Personal

By | June 2, 2015

The National Cancer Institute is launching a Phase 2 trial matching patients with specific mutations to drugs tailored to those genetic changes.

0 Comments

image: Clinical Matchmaker

Clinical Matchmaker

By | June 1, 2015

Enrolling the right patient population could be key to a successful clinical trial.

0 Comments

image: Resistance Fighter

Resistance Fighter

By | June 1, 2015

Stuart Levy has spent a lifetime studying mechanisms of antibiotic resistance and crusading to abolish the use of antibiotics in animal feed.

0 Comments

image: Viral Immunotherapy for Melanoma

Viral Immunotherapy for Melanoma

By | May 28, 2015

Phase 3 data from a clinical trial show a positive response to a melanoma treatment based on a modified herpesvirus.

0 Comments

Advertisement

Popular Now

  1. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

  2. Most Earth-like Planet Found
  3. Ancient Viruses as Gene Therapy Vectors
  4. Judge Decides on GM Rice Retraction
Advertisement
PDA
PDA
Advertisement